Mechanism of Action of NLRP3 Protein Macromolecule Based on Electrochemical Sensors in the Treatment of Alopecia Areata in Mice: The Role of Ritlecitinib in AA Mice Through NLRP3

    March 2026 in “ Microchemical Journal ”
    Yan Chang, Jianping Zhou, Linna Lv … Wenxia Zhang
    Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

    We don't know much about this study yet.

    Read the full study on sciencedirect.com →
    Discuss this study in the Community →

    Research cited in this study 16

    1. The AHR Pathway Is Dysregulated in Alopecia Areata Journal of Translational Autoimmunity · 2025
    2. Efficacy and Safety of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, in Adolescent and Adult Patients with Alopecia Totalis and Alopecia Universalis The Journal of Dermatology · 2024
    3. Hair Regrowth in Alopecia Areata and Re-Pigmentation in Vitiligo in Response to Treatment: Commonalities and Differences Journal of the European Academy of Dermatology and Venereology · 2024
    4. Total Glucosides of Paeony Inhibit NLRP3/Caspase-1/GSDMD-Mediated Inflammation and Pyroptosis in C3H/HeJ Mice With Alopecia Areata Biomolecules and Biomedicine · 2024
    5. Deciphering the Complex Immunopathogenesis of Alopecia Areata International Journal of Molecular Sciences · 2024
    6. Amygdalin Ameliorates Alopecia Areata on C3H/HeJ Mice by Inhibiting Inflammation Through JAK2/STAT3 Pathway Journal of Ethnopharmacology · 2024
    7. Elevation of Circulating DNAs of Disease-Associated Cytokines in Serum Cell-Free DNA from Patients with Alopecia Areata Bioscience trends · 2024
    8. Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program American journal of clinical dermatology · 2024
    9. Inhibition of T-Cell Activity in Alopecia Areata: Recent Developments and New Directions Frontiers in immunology · 2023
    10. Ritlecitinib: First Approval Drugs · 2023
    11. Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review Genes · 2023
    12. Aberrant Inflammasome Activation as a Driving Force of Human Autoimmune Skin Disease Frontiers in immunology · 2023
    13. Efficacy and Safety of Ritlecitinib in Adults and Adolescents With Alopecia Areata: A Randomised, Double-Blind, Multicentre, Phase 2b–3 Trial The Lancet · 2023
    14. How Our Microbiome Influences the Pathogenesis of Alopecia Areata Genes · 2022
    15. The Efficacy and Safety of JAK Inhibitors for Alopecia Areata: A Systematic Review and Meta-Analysis of Prospective Studies Frontiers in pharmacology · 2022
    16. Hair Follicle Immune Privilege and Its Collapse in Alopecia Areata Experimental dermatology · 2020